The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Medicine > Amarillo Biosciences, Inc.

Amarillo Biosciences, Inc.
OTC: AMAR
Change
symbol:
     
 PROFILE
Amarillo: home to cattlemen, prairies, and interferon? Development-stage Amarillo Biosciences hopes its interferon alpha (IFNa), which modulates the immune system, will help those suffering from a range of maladies, including hepatitis, fibromyalgia (chronic stiffness of the joints), and Sjogren's syndrome, a condition that leaves tissues painfully dry. The FDA has granted orphan drug status to IFNa to treat Behcet's disease, the chronic inflammation of blood vessels. Japanese firm Hayashibara Biochemical Laboratories, Amarillo Biosciences' primary development partner, owns nearly 45% of the company.

 COMPETITION
Biogen, Inc. (BGEN)
Genentech, Inc. (DNA)
Interferon Sciences, Inc. (IFSC)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 0.10
Employees: 7
Revenue per employee: $14,285.71

 KEY PEOPLE
• Joseph M. Cummins
    CEO
• Joseph M. Cummins
    CFO

 CONTACT INFO
800 W. 9th Ave.
Amarillo, TX 79101
US
Phone: 806-376-1741
Fax: 806-376-9301
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001